Van Damme P - Search Results

1

Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome.

Van Damme P, Vranckx R, Meheus A. Van Damme P, et al. Vaccine. 1990 Mar;8 Suppl:S53-5; discussion S60-2. doi: 10.1016/0264-410x(90)90236-f. Vaccine. 1990. PMID: 2139285 Clinical Trial.

2

Cost-effectiveness analysis of hepatitis A prevention in travellers.

Tormans G, Van Damme P, Van Doorslaer E. Tormans G, et al. Among authors: van doorslaer e, van damme p. Vaccine. 1992;10 Suppl 1:S88-92. doi: 10.1016/0264-410x(92)90554-w. Vaccine. 1992. PMID: 1335668

3

Heat stability of a recombinant DNA hepatitis B vaccine.

Van Damme P, Cramm M, Safary A, Vandepapelière P, Meheus A. Van Damme P, et al. Vaccine. 1992;10(6):366-7. doi: 10.1016/0264-410x(92)90064-q. Vaccine. 1992. PMID: 1534639 Clinical Trial.

4

Hepatitis C in institutionalized children.

Vranckx R, Van Damme P. Vranckx R, et al. Among authors: van damme p. N Engl J Med. 1990 Jul 5;323(1):64. doi: 10.1056/NEJM199007053230115. N Engl J Med. 1990. PMID: 2113186 No abstract available.

5

Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients.

Van Damme P, Vranckx R, Safary A, André FE, Meheus A. Van Damme P, et al. Am J Med. 1989 Sep 4;87(3A):26S-29S. doi: 10.1016/0002-9343(89)90527-5. Am J Med. 1989. PMID: 2528294

6

Age and immune response to hepatitis B vaccine in mentally handicapped.

Reniers J, Vranckx R, Heremans G, Van Damme P, Meheus A. Reniers J, et al. Among authors: van damme p. Arch Belg. 1986;44(11-12):489-93. Arch Belg. 1986. PMID: 2960279 No abstract available.

7

Hepatitis B prevention in Europe: a preliminary economic evaluation.

Van Damme P, Tormans G, Beutels P, Van Doorslaer E. Van Damme P, et al. Among authors: van doorslaer e. Vaccine. 1995;13 Suppl 1:S54-7. doi: 10.1016/0264-410x(95)93549-o. Vaccine. 1995. PMID: 7571833 Free article.

8

Horizontal transmission of hepatitis B virus.

Van Damme P, Cramm M, Van der Auwera JC, Vranckx R, Meheus A. Van Damme P, et al. Among authors: van der auwera jc. Lancet. 1995 Jan 7;345(8941):27-9. doi: 10.1016/s0140-6736(95)91155-3. Lancet. 1995. PMID: 7799703

9

Increased risk for hepatitis A among female day nursery workers in Belgium.

Jacques P, Moens G, Van Damme P, Goubau P, Vranckx R, Steeno J, Muylle L, Desmyter J. Jacques P, et al. Among authors: van damme p. Occup Med (Lond). 1994 Dec;44(5):259-61. doi: 10.1093/occmed/44.5.259. Occup Med (Lond). 1994. PMID: 7841420

10

Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity.

Van Damme P, Matheï C, Thoelen S, Meheus A, Safary A, André FE. Van Damme P, et al. J Med Virol. 1994 Dec;44(4):435-41. doi: 10.1002/jmv.1890440422. J Med Virol. 1994. PMID: 7897376 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,264 results

Search Page

Filters